Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRAVITI PHARMS

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 37
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

BAJAJ

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 31
  • 0 comments

FDA approve LACTULOSE

Comment Full text

BIONPHARMA

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 37
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

COSETTE

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 36
  • 0 comments

FDA approve NITROGLYCERIN

Comment Full text

LUPIN

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 39
  • 0 comments

FDA approve DIMETHYL FUMARATE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 31
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

ALVOGEN

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 36
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

HISUN PHARM HANGZHOU

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 40
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

LUPIN LTD

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 42
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Comment Full text

MYLAN

  • FDA Approval
  • Feb. 21, 2024, 10:03 UTC
  • 37
  • 0 comments

FDA approve ESTROPIPATE

Comment Full text
  • Previous
  • 545
  • 546
  • 547
  • 548
  • 549
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143307)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin